mianserin has been researched along with fenfluramine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Leitch, IM; Rawlow, A; Rechtman, MP | 1 |
Braszko, JJ; Maciejewski, A; Majewski, K; Wisniewski, K | 1 |
Broekkamp, CL; Garrigou, D; LLoyd, KG | 1 |
BrÄtveit-Johansen, K; Malt, UF; Tanum, L | 1 |
Grisaru, N; Levkovitz, Y; Segal, M | 1 |
Clifton, PG; Dourish, CT; Kennett, GA; Lee, MD; Somerville, EM | 1 |
1 trial(s) available for mianserin and fenfluramine
Article | Year |
---|---|
Fenfluramine challenge test predicts outcome in pharmacological treatment of patients with functional gastrointestinal disorder.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Colonic Diseases, Functional; Double-Blind Method; Female; Fenfluramine; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Patient Selection; Predictive Value of Tests; Prolactin; Serotonin Agents; Serotonin Antagonists; Treatment Outcome | 1999 |
8 other study(ies) available for mianserin and fenfluramine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Pharmacological evaluation of two novel analogues of mianserin: 2-N-carboxamidinonormianserin (FCC5) and 2-N-carboxamidonormianserin (FCC13).
Topics: Animals; Blood Pressure; Bronchoconstriction; Catalepsy; Central Nervous System; Decerebrate State; Edema; Female; Fenfluramine; Guinea Pigs; Histamine H1 Antagonists; Male; Mianserin; Mice; Morphine; Rats; Rats, Inbred Strains; Reflex; Serotonin; Serotonin Antagonists | 1992 |
Effect of angiotensin II on some behavioral and neurochemical measures of the central serotonine system.
Topics: 5-Hydroxytryptophan; Angiotensin II; Animals; Behavior, Animal; Brain Chemistry; Cyproheptadine; Electroshock; Fenfluramine; Hydroxylation; Injections, Intraventricular; Kinetics; Male; Mianserin; Physostigmine; Rats; Rats, Inbred Strains; Serotonin; Tryptophan | 1985 |
Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomised rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Clonidine; Ergolines; Fenfluramine; Fluoxetine; Imipramine; Male; Metergoline; Mianserin; Olfactory Bulb; Quipazine; Rats; Serotonin; Serotonin Antagonists | 1980 |
Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Desipramine; Electric Stimulation; Electric Stimulation Therapy; Excitatory Postsynaptic Potentials; Fenfluramine; Hippocampus; Long-Term Potentiation; Male; Mianserin; Neural Inhibition; Neurons; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Transcranial Magnetic Stimulation | 2001 |
Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice.
Topics: Animals; Binding Sites; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Eating; Ergolines; Fenfluramine; Genotype; Injections, Intraperitoneal; Injections, Subcutaneous; Isomerism; Mianserin; Mice; Mice, Knockout; Piperazines; Piperidones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Satiation; Satiety Response; Serotonin 5-HT2 Receptor Agonists; Species Specificity; Spiperone; Spiro Compounds; Time Factors; Tritium; United Kingdom | 2004 |